NCT00889967 - "Safety and Efficacy Study of Ciprofloxacin for Inhalation in Patients With Non-Cystic Fibrosis Bronchiectasis ORBIT-1" | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

April 30, 2011

Study Completion Date

June 30, 2011

Conditions

Non-Cystic Fibrosis Bronchiectasis

Interventions

DRUG

Ciprofloxacin for Inhalation

100 mg once daily by inhalation for 28 days

DRUG

Ciprofloxacin for Inhalation

150 mg once daily by inhalation for 28 days

DRUG

Placebo

Placebo once daily by inhalation for 28 days

Trial Locations (37)

10016

New York

13353

Berlin

19104

Philadelphia

27909

Elizabeth City

33136

Miami

33511

Brandon

43614

Toledo

51503

Council Bluffs

56564

Neuwied

69126

Heidelberg

75069

McKinney

85006

Phoenix

90048

Los Angeles

90505

Torrance

93093

Donaustauf

95819

Sacramento

06708

Waterbury

07901

Summit

T2N 1L9

Calgary

V1Y 1E4

Kelowna

V5Z 1M9

Vancouver

V5Z 4E1

Vancouver

K1Y 4E9

Ottawa

H2W 1T8

Montreal

J7Z 5T3

Saint-Jérôme

BT9 7AB

"Ground Floor, Tower Block, Lisburn Road", Belfast

Unknown

"1st Floor, Nuffield House, B15 2TH", Birmingham

"Southmoor Road, M23 9LT", Manchester

BD9 6RJ

"Duckworth Lane,", Bradford

NE7 7DN

Newcastle upon Tyne

SE13 6LH

London

B9 5SS

"Bordesley Green East", Birmingham

G21 3UW

"133 Balornock Road", Glasgow

SW3 6NP

Royal Brompton Hospital, London

M6 8HD

"Stott Lane", Salford

ST4 6QG

"Newcastle Road", Stoke-on-Trent

NE29 8NH

"Northumbria Healthcare", Tyne and Wear